BioCentury | Jul 2, 2007
Finance

Calling card put away

...BioVentures. Platzer said Ingenium had raised more than E80 million in financing from investors including Schroder Ventures...
BioCentury | Apr 10, 2006
Strategy

Home run in extra innings

...$40 million was raised in a series B round in 2003, which included MPM Capital; Schroder Ventures...
BioCentury | Apr 10, 2006
Finance

Ebb & Flow

...$13.6 million last year. The company's principal stockholders include Atlas (22.1% prior to the IPO); Schroder Ventures...
BioCentury | Jan 16, 2006
Strategy

The Lure of capital

Last week's reverse merger of Micromet AG into publicly held CancerVax Corp. provides the German cancer play with an estimated $40-$50 million in cash - in the top half of what companies at its stage of...
BioCentury | Jun 11, 2005
Company News

Eyetech names Simon chairman

...resigned. Simon has been an EYET director since July 2001 and is a partner at Schroder Ventures...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...$67.4 Swissfirst; Temasek Capital; Carnegie Asset Management; CDIB BioScience Ventures; CITA; MVI Medical Venture Investments; Schroder Ventures...
...PharmaBio Development; Apax Partners; TVM Techno Venture Management; Earlybird; and other investors PowderMed U.K. $35.2 Schroder Ventures...
BioCentury | Jan 3, 2005
Finance

Value-driven in Europe

...as exits but as an opportunity to access new capital. Kate Bingham, general partner at Schroder Ventures...
BioCentury | Sep 6, 2004
Finance

Ebb & Flow

...new CEO, Michael Kishbauch, and $10.4 million in a bridge financing from existing investors Atlas; Schroder Ventures...
BioCentury | Sep 2, 2004
Financial News

Achillion raises $10.4 million

...the company's series D round, which is expected to close this year. Investors included Atlas; Schroder Ventures...
BioCentury | Aug 4, 2004
Financial News

Avera raises $48M

...C round led by Perseus-Soros BioPharmaceutical. Other investors in the autoimmune and neurology company included Schroder Ventures...
...Windamere Venture. Steven Elms, managing director of Perseus-Soros BioPharmaceutical, and Lutz Giebel, venture partner at Schroder Ventures...
Items per page:
1 - 10 of 122
BioCentury | Jul 2, 2007
Finance

Calling card put away

...BioVentures. Platzer said Ingenium had raised more than E80 million in financing from investors including Schroder Ventures...
BioCentury | Apr 10, 2006
Strategy

Home run in extra innings

...$40 million was raised in a series B round in 2003, which included MPM Capital; Schroder Ventures...
BioCentury | Apr 10, 2006
Finance

Ebb & Flow

...$13.6 million last year. The company's principal stockholders include Atlas (22.1% prior to the IPO); Schroder Ventures...
BioCentury | Jan 16, 2006
Strategy

The Lure of capital

Last week's reverse merger of Micromet AG into publicly held CancerVax Corp. provides the German cancer play with an estimated $40-$50 million in cash - in the top half of what companies at its stage of...
BioCentury | Jun 11, 2005
Company News

Eyetech names Simon chairman

...resigned. Simon has been an EYET director since July 2001 and is a partner at Schroder Ventures...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...$67.4 Swissfirst; Temasek Capital; Carnegie Asset Management; CDIB BioScience Ventures; CITA; MVI Medical Venture Investments; Schroder Ventures...
...PharmaBio Development; Apax Partners; TVM Techno Venture Management; Earlybird; and other investors PowderMed U.K. $35.2 Schroder Ventures...
BioCentury | Jan 3, 2005
Finance

Value-driven in Europe

...as exits but as an opportunity to access new capital. Kate Bingham, general partner at Schroder Ventures...
BioCentury | Sep 6, 2004
Finance

Ebb & Flow

...new CEO, Michael Kishbauch, and $10.4 million in a bridge financing from existing investors Atlas; Schroder Ventures...
BioCentury | Sep 2, 2004
Financial News

Achillion raises $10.4 million

...the company's series D round, which is expected to close this year. Investors included Atlas; Schroder Ventures...
BioCentury | Aug 4, 2004
Financial News

Avera raises $48M

...C round led by Perseus-Soros BioPharmaceutical. Other investors in the autoimmune and neurology company included Schroder Ventures...
...Windamere Venture. Steven Elms, managing director of Perseus-Soros BioPharmaceutical, and Lutz Giebel, venture partner at Schroder Ventures...
Items per page:
1 - 10 of 122